Preparation of antibody-modified lipid (DSPE-PEG (2k)-Ab)

FH Fumika Hirabayashi
KI Kenjiro Iwanaga
TO Toshinori Okinaga
OT Osamu Takahashi
WA Wataru Ariyoshi
RS Ryo Suzuki
MS Mutsumi Sugii
KM Kazuo Maruyama
KT Kazuhiro Tominaga
TN Tatsuji Nishihara
request Request a Protocol
ask Ask a question
Favorite

We dissolved 3-(N-succinimidyloxyglutaryl) aminopropyl, polyethyleneglycol 2000-carbamoyl distearoyl-phosphoethanolamine (DSPE-PEG (2k)-NHS, SUNBRIGHT DSPE-020GS; NOF Corporation, Tokyo, Japan) (0.123 mg) in chloroform. The lipid solution was evaporated to make a lipid film in a glass tube by chloroform removal. Then, the antibody solution (0.125 mg/mL, 0.56 mL) in PBS (pH 7.4) was added to the lipid film. The lipid film was rehydrated with antibody solution to conjugate the antibody to DSPE-PEG (2k)-NHS. The sample was incubated at 60°C for 5 min, and then at room temperature for 1 h to obtain the antibody-conjugated PEG-lipid (DSPE-PEG (2k)-Ab).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A